{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicxr6vwydxlm3dyvsyb5nzjqeaba4btxyjenw5lppcdqdzbefp4ga",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mm3dol5xe2i2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifyr7ldu4h4yif24e5zgojtmu5rvekqo7fhigu7g2cgccngzmpize"
    },
    "mimeType": "image/jpeg",
    "size": 415057
  },
  "path": "/news/2026-05-weight-loss-drugs-death-recurrence.html",
  "publishedAt": "2026-05-17T17:00:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "New research published in JAMA Network Open suggests that there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.",
  "title": "Weight-loss drugs tied to lower death, recurrence risk after breast cancer"
}